BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 21411975)

  • 21. Toll-Like Receptors in Natural Killer Cells and Their Application for Immunotherapy.
    Noh JY; Yoon SR; Kim TD; Choi I; Jung H
    J Immunol Res; 2020; 2020():2045860. PubMed ID: 32377528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deciphering the Immunological Phenomenon of Adaptive Natural Killer (NK) Cells and Cytomegalovirus (CMV).
    Barnes S; Schilizzi O; Audsley KM; Newnes HV; Foley B
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of natural killer cells by hepatitis C virus particles in vitro.
    Farag MM; Weigand K; Encke J; Momburg F
    Clin Exp Immunol; 2011 Sep; 165(3):352-62. PubMed ID: 21682720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innate or adaptive immunity? The example of natural killer cells.
    Vivier E; Raulet DH; Moretta A; Caligiuri MA; Zitvogel L; Lanier LL; Yokoyama WM; Ugolini S
    Science; 2011 Jan; 331(6013):44-9. PubMed ID: 21212348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tricking the balance: NK cells in anti-cancer immunity.
    Pahl J; Cerwenka A
    Immunobiology; 2017 Jan; 222(1):11-20. PubMed ID: 26264743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful control of viruses by NK cells--a balance of opposing forces?
    Scalzo AA
    Trends Microbiol; 2002 Oct; 10(10):470-4. PubMed ID: 12377557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evolutionary arms race between NK cells and viruses: who gets the short end of the stick?
    Miletić A; Krmpotić A; Jonjić S
    Eur J Immunol; 2013 Apr; 43(4):867-77. PubMed ID: 23440773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural killer cell specificity for viral infections.
    Hammer Q; Rückert T; Romagnani C
    Nat Immunol; 2018 Aug; 19(8):800-808. PubMed ID: 30026479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initial and innate responses to viral infections--pattern setting in immunity or disease.
    Biron CA
    Curr Opin Microbiol; 1999 Aug; 2(4):374-81. PubMed ID: 10458991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NK Cell Hyporesponsiveness: More Is Not Always Better.
    Frutoso M; Mortier E
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31547251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of natural killer cell activity by viruses.
    Lisnić VJ; Krmpotić A; Jonjić S
    Curr Opin Microbiol; 2010 Aug; 13(4):530-9. PubMed ID: 20558100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Innate immunity defines the capacity of antiviral T cells to limit persistent infection.
    Andrews DM; Estcourt MJ; Andoniou CE; Wikstrom ME; Khong A; Voigt V; Fleming P; Tabarias H; Hill GR; van der Most RG; Scalzo AA; Smyth MJ; Degli-Esposti MA
    J Exp Med; 2010 Jun; 207(6):1333-43. PubMed ID: 20513749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural killer cell immune responses.
    Yokoyama WM
    Immunol Res; 2005; 32(1-3):317-25. PubMed ID: 16106081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Role of Natural Killer Cells in Autoimmune Diseases.
    Kucuksezer UC; Aktas Cetin E; Esen F; Tahrali I; Akdeniz N; Gelmez MY; Deniz G
    Front Immunol; 2021; 12():622306. PubMed ID: 33717125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural killer cells promote early CD8 T cell responses against cytomegalovirus.
    Robbins SH; Bessou G; Cornillon A; Zucchini N; Rupp B; Ruzsics Z; Sacher T; Tomasello E; Vivier E; Koszinowski UH; Dalod M
    PLoS Pathog; 2007 Aug; 3(8):e123. PubMed ID: 17722980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roles of natural killer cells in antiviral immunity.
    Waggoner SN; Reighard SD; Gyurova IE; Cranert SA; Mahl SE; Karmele EP; McNally JP; Moran MT; Brooks TR; Yaqoob F; Rydyznski CE
    Curr Opin Virol; 2016 Feb; 16():15-23. PubMed ID: 26590692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural Killer Cells: Development, Maturation, and Clinical Utilization.
    Abel AM; Yang C; Thakar MS; Malarkannan S
    Front Immunol; 2018; 9():1869. PubMed ID: 30150991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection.
    Cretney E; Degli-Esposti MA; Densley EH; Farrell HE; Davis-Poynter NJ; Smyth MJ
    J Exp Med; 1999 Aug; 190(3):435-44. PubMed ID: 10430631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of combination NK/KIRs in the natural history of viral infections.].
    Colomba C; Cascio A; Caruso C; Trizzino M; Gioè C; Guadagnino G; Tuttolomondo A; Pinto A; Saracino A; Angarano G; Di Bona D;
    Recenti Prog Med; 2017; 108(7):333-337. PubMed ID: 28845855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human NK cells, their receptors and function.
    Quatrini L; Della Chiesa M; Sivori S; Mingari MC; Pende D; Moretta L
    Eur J Immunol; 2021 Jul; 51(7):1566-1579. PubMed ID: 33899224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.